Consortium of Private Equity Funds Acquires Pharmaceutical Group

Represented a consortium of private equity funds on their acquisition of a controlling stake in a leading pharmaceutical group and the subsequent refinancing of such group’s existing facilities.

The Faegre Baker Daniels website uses cookies to make your browsing experience as useful as possible. In order to have the full site experience, keep cookies enabled on your web browser. By browsing our site with cookies enabled, you are agreeing to their use. Review Faegre Baker Daniels' cookies information for more details.